E-LIB Suche - Ergebnisse für: Blauvelt, Andrew

1

Long-term safety of Ixekizumab in adults with psoriasis, ps..:

Deodhar, Atul ; Blauvelt, Andrew ; Lebwohl, Mark...
Arthritis Research & Therapy. 26 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Deucravacitinib onset of action and maintenance of response..:

Korman, Neil J. ; Warren, Richard B. ; Bagel, Jerry...
Journal of Dermatological Treatment. 35 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

53833 Long-term Safety and Efficacy of Risankizumab for the..:

Papp, Kim A. ; Lebwohl, Mark G. ; Puig, Lluís...
Journal of the American Academy of Dermatology. 91 (2024) 3 - p. AB60 , 2024

Link: https://doi.org/10.1016/..

4

52661 Bimekizumab 4-year maintenance of responses in Week 1..:

Blauvelt, Andrew ; Foley, Peter ; Langley, Richard G....
Journal of the American Academy of Dermatology. 91 (2024) 3 - p. AB23 , 2024

Link: https://doi.org/10.1016/..

5

Predicting Abrocitinib Efficacy at Week 12 Based on Clinica..:

Armstrong, April W. ; Alexis, Andrew F. ; Blauvelt, Andrew...
Dermatology and Therapy. 14 (2024) 7 - p. 1849-1861 , 2024

Link: https://doi.org/10.1007/..

6

Differential Pharmacodynamic Effects on Psoriatic Biomarker..:

Blauvelt, Andrew ; Chen, Yanqing ; Branigan, Patrick J....
JID Innovations. 4 (2024) 5 - p. 100297 , 2024

Link: https://doi.org/10.1016/..

7

53971 Correlation of Vitiligo Area Scoring Index With Vitil..:

van Geel, Nanja ; Blauvelt, Andrew ; Pandya, Amit G....
Journal of the American Academy of Dermatology. 91 (2024) 3 - p. AB29 , 2024

Link: https://doi.org/10.1016/..

8

527 - Efficacy of upadacitinib for moderate-to-severe atopi..:

Blauvelt, Andrew ; Calimlim, Brian M ; Liu, Yingyi..
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii29-ii30 , 2024

Link: https://doi.org/10.1093/..

9

551 - Continuous tralokinumab treatment over 4 years in adu..:

Blauvelt, Andrew ; Langley, Richard G ; Peris, Ketty...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii48-ii49 , 2024

Link: https://doi.org/10.1093/..

10

Rapid resolution of guttate psoriasis without recurrence fo..:

Abbad‐Jaime de Aragón, Carlota ; Berna‐Rico, Emilio ; Jaén, Pedro..
International Journal of Dermatology. 63 (2024) 4 - p. 534-535 , 2024

Link: https://doi.org/10.1111/..

11

Improvement of the Head and Neck Regions with Continuous Tr..:

Chovatiya, Raj ; Wollenberg, Andreas ; Ribero, Simone...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s316 , 2024

Link: https://doi.org/10.25251..

12

Six-Month Real-World Study to Assess the Effectiveness of I..:

Lebwohl, Mark ; Strober, Bruce ; Schrader, Amy...
Drugs - Real World Outcomes. 11 (2024) 3 - p. 451-464 , 2024

Link: https://doi.org/10.1007/..

13

Long-Term Safety of Risankizumab in Patients with Psoriatic..:

Gordon, Kenneth B. ; Blauvelt, Andrew ; Bachelez, Hervé...
Dermatology and Therapy. 14 (2024) 9 - p. 2523-2538 , 2024

Link: https://doi.org/10.1007/..

14

Deucravacitinib in moderate‐to‐severe plaque psoriasis: Poo..:

Strober, Bruce ; Blauvelt, Andrew ; Warren, Richard B....
Journal of the European Academy of Dermatology and Venereology. 38 (2024) 8 - p. 1543-1554 , 2024

Link: https://doi.org/10.1111/..

15

Association Between Early Clinical Responses and Long-Term ..:

Prajapati, Vimal H. ; Geng, Bob ; Blauvelt, Andrew...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s373 , 2024

Link: https://doi.org/10.25251..